Organogenesis Holdings
ORGO
17 hedge funds and large institutions have $109M invested in Organogenesis Holdings in 2017 Q1 according to their latest regulatory filings, with 17 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
35.45% more ownership
Funds ownership: 0% → 35.45% (+35%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Assured Investment Management
New York
|
+$24.7M |
| 2 |
Fir Tree Capital Management
New York
|
+$17.8M |
| 3 |
Hutchin Hill Capital
New York
|
+$14.7M |
| 4 |
Moore Capital Management
New York
|
+$14.7M |
| 5 |
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$10.3M |
Top Sellers
ORGO Hedge Fund Activity: Q1 2017 in Review
17 of the 4,035 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q1 2017, worth a combined $109M.
Buyers outnumbered sellers: 17 funds opened new ORGO positions and 0 closed out — a net gain of 17 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Assured Investment Management, opening a new position worth an estimated $24.7M.
- 17 institutional investors held Organogenesis Holdings (ORGO) as of Q1 2017, up from 0 in Q4 2016.
- Funds reported $109M of Organogenesis Holdings stock for Q1 2017.
- 17 funds opened new Organogenesis Holdings positions in Q1 2017 and 0 closed out, a net change of +17 holders.
- The largest Organogenesis Holdings buyer in Q1 2017 was Assured Investment Management, an estimated $24.7M added.
Based on aggregated 13F filings for Q1 2017.